ZYUS Life Sciences Corp. (TSX.V: ZYUS) Featured in Coverage of the 36th Annual Roth Conference
ZYUS (TSX.V: ZYUS) is a life sciences company focused on the global development and commercialization of novel cannabinoid-based pharmaceutical drug product candidates for pain management. Through scientific discovery and clinical research, ZYUS is committed to advancing non-opioid-based pharmaceutical products. Our active engagement in intellectual property activities aims to safeguard these novel therapies, with the goal of developing them into regulatory approved, prescription medications that will…